Fly News Breaks for June 23, 2017
NVS
Jun 23, 2017 | 06:34 EDT
Barclays analyst Emmanuel Papadakis upgraded Novartis to Equal Weight following better than expected CANTOS results.
News For NVS From the Last 2 Days
NVS
Apr 24, 2024 | 07:26 EDT
TD Cowen analyst Yaron Werber raised the firm's price target on BeiGene (BGNE) to $236 from $235 and keeps a Buy rating on the shares. The firm updated its model to reflect lower collaborative revenue given termination of Novartis (NVS) agreement for tisle in Sep 2023.